LINC02515

Across TCGA pan-cancer cohorts, LINC02515 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02515’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02515 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02515 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC, BRCA, and PRAD are the cancer types where LINC02515 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02515 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.372	<.001	9	view →
BRCA	All	III,IV	−1.833	<.001	6	view →
PRAD	All	All	+0.280	<.001	2	view →
KICH	All	All	+0.105	.045	1	view →
LUSC	All	All	+0.067	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02515–KIRC

Open the KIRC breakdown →